메뉴 건너뛰기




Volumn 394, Issue 2, 2010, Pages 366-371

In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1 receptor antagonist for the management of obesity

Author keywords

Cannabinoid CB1 receptor antagonist; CP 945,598; Energy expenditure; Feeding; Obesity

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CE 156706; DRUG METABOLITE; OTENABANT; RIMONABANT; UNCLASSIFIED DRUG;

EID: 77950188010     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.015     Document Type: Article
Times cited : (22)

References (23)
  • 1
    • 26044461277 scopus 로고    scopus 로고
    • Endocannabinoids in the regulation of appetite and body weight
    • Kirkham T.C. Endocannabinoids in the regulation of appetite and body weight. Behav. Pharmacol. 16 (2005) 297-313
    • (2005) Behav. Pharmacol. , vol.16 , pp. 297-313
    • Kirkham, T.C.1
  • 2
    • 0028129936 scopus 로고
    • SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
    • Rinaldi-Carmona M., Barth F., Heaulme M., et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350 (1994) 240-244
    • (1994) FEBS Lett. , vol.350 , pp. 240-244
    • Rinaldi-Carmona, M.1    Barth, F.2    Heaulme, M.3
  • 4
  • 5
    • 32644441249 scopus 로고    scopus 로고
    • Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial
    • Pi-Sunyer F.X., Aronne L.J., Heshmati H.M., Devin J., and Rosenstock J. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295 (2006) 761-775
    • (2006) JAMA , vol.295 , pp. 761-775
    • Pi-Sunyer, F.X.1    Aronne, L.J.2    Heshmati, H.M.3    Devin, J.4    Rosenstock, J.5
  • 6
    • 17144382751 scopus 로고    scopus 로고
    • Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
    • Van Gaal L.F., Rissanen A.M., Scheen A.J., Ziegler O., and Rossner S. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365 (2005) 1389-1397
    • (2005) Lancet , vol.365 , pp. 1389-1397
    • Van Gaal, L.F.1    Rissanen, A.M.2    Scheen, A.J.3    Ziegler, O.4    Rossner, S.5
  • 7
    • 33751001942 scopus 로고    scopus 로고
    • Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
    • Scheen A.J., Finer N., Hollander P., Jensen M.D., and Van Gaal L.F. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 368 (2006) 1660-1672
    • (2006) Lancet , vol.368 , pp. 1660-1672
    • Scheen, A.J.1    Finer, N.2    Hollander, P.3    Jensen, M.D.4    Van Gaal, L.F.5
  • 8
    • 27844463517 scopus 로고    scopus 로고
    • Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
    • Despres J.P., Golay A., and Sjostrom L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 353 (2005) 2121-2134
    • (2005) N. Engl. J. Med. , vol.353 , pp. 2121-2134
    • Despres, J.P.1    Golay, A.2    Sjostrom, L.3
  • 9
    • 34249849860 scopus 로고    scopus 로고
    • Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
    • Bronander K.A., and Bloch M.J. Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data. Vasc. Health Risk Manage. 3 (2007) 181-190
    • (2007) Vasc. Health Risk Manage. , vol.3 , pp. 181-190
    • Bronander, K.A.1    Bloch, M.J.2
  • 10
    • 60549088559 scopus 로고    scopus 로고
    • Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-Yl]-4-ethylaminopiperidine-4-carboxylic acid amine hydrochloride (CP-945,598), a novel, potent and selective cannabinoid CB1 receptor antagonist
    • Griffith D.A., Hadcock J.R., Black S.C., et al. Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-Yl]-4-ethylaminopiperidine-4-carboxylic acid amine hydrochloride (CP-945,598), a novel, potent and selective cannabinoid CB1 receptor antagonist. J. Med. Chem. 52 (2009) 234-237
    • (2009) J. Med. Chem. , vol.52 , pp. 234-237
    • Griffith, D.A.1    Hadcock, J.R.2    Black, S.C.3
  • 11
    • 0029859983 scopus 로고    scopus 로고
    • Identification and characterization of novel somatostatin antagonists
    • Bass R.T., Buckwalter B.L., Patel B.P., et al. Identification and characterization of novel somatostatin antagonists. Mol. Pharmacol. 50 (1996) 709-715
    • (1996) Mol. Pharmacol. , vol.50 , pp. 709-715
    • Bass, R.T.1    Buckwalter, B.L.2    Patel, B.P.3
  • 15
    • 0031032872 scopus 로고    scopus 로고
    • SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice
    • Richardson J.D., Aanonsen L., and Hargreaves K.M. SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur. J. Pharmacol. 319 (1997) R3-R4
    • (1997) Eur. J. Pharmacol. , vol.319
    • Richardson, J.D.1    Aanonsen, L.2    Hargreaves, K.M.3
  • 17
    • 18444376760 scopus 로고    scopus 로고
    • International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
    • Howlett A.C., Barth F., Bonner T.I., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54 (2002) 161-202
    • (2002) Pharmacol. Rev. , vol.54 , pp. 161-202
    • Howlett, A.C.1    Barth, F.2    Bonner, T.I.3
  • 19
    • 23044447712 scopus 로고    scopus 로고
    • Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice
    • Varvel S.A., Bridgen D.T., Tao Q., Thomas B.F., Martin B.R., and Lichtman A.H. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. J. Pharmacol. Exp. Ther. 314 (2005) 329-337
    • (2005) J. Pharmacol. Exp. Ther. , vol.314 , pp. 329-337
    • Varvel, S.A.1    Bridgen, D.T.2    Tao, Q.3    Thomas, B.F.4    Martin, B.R.5    Lichtman, A.H.6
  • 20
    • 0032541111 scopus 로고    scopus 로고
    • Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
    • Colombo G., Agabio R., Diaz G., Lobina C., Reali R., and Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 63 (1998) PL113-PL117
    • (1998) Life Sci. , vol.63
    • Colombo, G.1    Agabio, R.2    Diaz, G.3    Lobina, C.4    Reali, R.5    Gessa, G.L.6
  • 21
    • 0038070321 scopus 로고    scopus 로고
    • Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats
    • Vickers S.P., Webster L.J., Wyatt A., Dourish C.T., and Kennett G.A. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology (Berlin) 167 (2003) 103-111
    • (2003) Psychopharmacology (Berlin) , vol.167 , pp. 103-111
    • Vickers, S.P.1    Webster, L.J.2    Wyatt, A.3    Dourish, C.T.4    Kennett, G.A.5
  • 22
    • 34249097103 scopus 로고    scopus 로고
    • Role of cannabinoid CB2 receptors in glucose homeostasis in rats
    • Bermudez-Silva F.J., Sanchez-Vera I., Suarez J., et al. Role of cannabinoid CB2 receptors in glucose homeostasis in rats. Eur. J. Pharmacol. 565 (2007) 207-211
    • (2007) Eur. J. Pharmacol. , vol.565 , pp. 207-211
    • Bermudez-Silva, F.J.1    Sanchez-Vera, I.2    Suarez, J.3
  • 23
    • 13244249625 scopus 로고    scopus 로고
    • Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice
    • Liu Y.L., Connoley I.P., Wilson C.A., and Stock M.J. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. Int. J. Obes. (Lond.) 29 (2005) 183-187
    • (2005) Int. J. Obes. (Lond.) , vol.29 , pp. 183-187
    • Liu, Y.L.1    Connoley, I.P.2    Wilson, C.A.3    Stock, M.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.